⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
ROSEN, A TOP-RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
accessnewswire.com
NKTR
Pomerantz LLP Files Class Action Lawsuit Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
NKTR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
globenewswire.com
NKTR
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
accessnewswire.com
NKTR
Pomerantz LLP Pursues Class Action Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
Pomerantz LLP Files Class Action Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR
MEDP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026 Ready to Announce with Confidence?
newsfilecorp.com
MEDP
LAKE
NKTR
NKTR CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
NKTR
Pomerantz LLP Moves to File Class Action Litigation Against Nektar Therapeutics – NKTR
accessnewswire.com
NKTR